Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
259 hedge funds and large institutions have $687M invested in Avanos Medical in 2024 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 78 increasing their positions, 62 reducing their positions, and 45 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 62
2% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 45
0.57% more ownership
Funds ownership: 93.33% → 93.91% (+0.57%)
0% less funds holding
Funds holding: 260 → 259 (-1)
12% less call options, than puts
Call options by funds: $88K | Put options by funds: $100K
33% less capital invested
Capital invested by funds: $1.03B → $687M (-$343M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$12.8M |
| 2 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
+$4.88M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$4.04M |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$3.22M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$14.5M |
| 2 |
Morgan Stanley
New York
|
-$12.5M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.87M |
| 4 |
RC
RGM Capital
Naples,
Florida
|
-$3.66M |
| 5 |
Goldman Sachs
New York
|
-$1.96M |
AVNS Hedge Fund Activity: Q4 2024 in Review
259 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2024, worth a combined $687M — down 33% from $1.03B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new AVNS positions and 45 closed out — a net gain of 1 holder — while 78 added to existing stakes and 62 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $12.8M. The largest seller was Westwood Holdings Group, cutting an estimated $14.5M.
- 259 institutional investors held Avanos Medical (AVNS) as of Q4 2024, down from 260 in Q3 2024.
- Funds reported $687M of Avanos Medical stock for Q4 2024, down 33% quarter-over-quarter.
- 46 funds opened new Avanos Medical positions in Q4 2024 and 45 closed out, a net change of +1 holder.
- The largest Avanos Medical buyer in Q4 2024 was T. Rowe Price Investment Management, an estimated $12.8M added.
- The largest Avanos Medical seller in Q4 2024 was Westwood Holdings Group, an estimated $14.5M sold.
Based on aggregated 13F filings for Q4 2024.